Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Haemophilia A (Moderate or Severe)”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Large-scale testing (Phase 3)Study completedNCT00189982
What this trial is testing

Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101

Who this might be right for
Hemophilia A
Baxalta now part of Shire 4
Large-scale testing (Phase 3)Study completedNCT03569891
What this trial is testing

HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients

Who this might be right for
Hemophilia B
CSL Behring 67
Not applicableStudy completedNCT00936845
What this trial is testing

Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study

Who this might be right for
Hemophilia AHemophilia B
Weill Medical College of Cornell University 22
Not applicableUnknownNCT02282410
What this trial is testing

Evaluate Efficacy and Safety of ADVATE in the Standard Prophylaxis Treatment of Severe or Moderately Severe Hemophilia A

Who this might be right for
Hemophilia A
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 15
Large-scale testing (Phase 3)Study completedNCT01488994
What this trial is testing

BAX 326 Pediatric Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 23
Large-scale testing (Phase 3)Study completedNCT03587116
What this trial is testing

Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

Who this might be right for
Hemophilia BHemophilia A
Pfizer 212
Early research (Phase 1)Study completedNCT02035605
What this trial is testing

An Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients

Who this might be right for
Hemophilia AHemophilia B
Sanofi 51
Post-approval studies (Phase 4)Study completedNCT00638001
What this trial is testing

Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy

Who this might be right for
Haemophilia AHaemophilia B
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 70
Post-approval studies (Phase 4)Active Not RecruitingNCT06752850
What this trial is testing

Investigate the Course of Synovial Hypertrophy in Patients With Haemophilia A on Efanesoctocog Alfa Prophylaxis

Who this might be right for
Haemophilia A (Moderate or Severe)Hemophilia, ClassicHaemophilia+3 more
Swedish Orphan Biovitrum 37
Not applicableStudy completedNCT01053715
What this trial is testing

Quality of Life Study of Helixate NexGen

Who this might be right for
Hemophilia A
CSL Behring 78
Large-scale testing (Phase 3)UnknownNCT02930317
What this trial is testing

Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemophilia A

Who this might be right for
Hemophilia A
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 60
Post-approval studies (Phase 4)Study completedNCT03449342
What this trial is testing

Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 60
Post-approval studies (Phase 4)Study completedNCT00243386
What this trial is testing

Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 82
Testing effectiveness (Phase 2)Study completedNCT03489291
What this trial is testing

Dose Confirmation Trial of AAV5-hFIXco-Padua

Who this might be right for
Hemophilia B
CSL Behring 3
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416
What this trial is testing

KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

Who this might be right for
Hemophilia a and B
Suzhou Alphamab Co., Ltd. 24
Testing effectiveness (Phase 2)Looking for participantsNCT05987449
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A

Who this might be right for
Hemophilia A
Hoffmann-La Roche 60
Post-approval studies (Phase 4)Study completedNCT01128881
What this trial is testing

IMMUNINE Pre-Treatment Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 57
Early research (Phase 1)Study completedNCT01921855
What this trial is testing

Study of FVIIa Variant BAY86-6150 (B0189) in Subjects With Moderate or Severe Hemophilia Types A or B With or Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Bayer 16
Testing effectiveness (Phase 2)Study completedNCT02554773
What this trial is testing

An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 34
Early research (Phase 1)Study completedNCT01579903
What this trial is testing

Relative Bioavailability Of Two Formulations Of Moroctocog Alfa (AF-CC)

Who this might be right for
Hemophilia A
Pfizer 16
Next Page